FUNDRAISING FOR A CURE

Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them

Breaking news courtesy of Carcinoid Cancer Foundation and perhaps providing a little hope for the future for NET patients – a Phase III clinical trial using targeted radiation for patients with intestinal carcinoid cancer that has spread beyond the intestine has opened at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute in Los Angeles, California. In this investigational therapy, a radioactive molecule, Lutathera, is targeted to attach to cancerous cells with little radiation exposure to the rest of the body. Read more about the Cedars-Sinai trial by clicking on the link.

Latest Posts
Archive Posts

READ ABOUT HOW FUNDS ARE USED

Subscribe to our Newsletter

Get informed about the latest news straight to your inbox

0